Navigating MOTS-c price comparisons requires evaluating more than nominal cost per vial; researchers must assess active peptide content, analytical verification, and manufacturing compliance. This guide outlines how to analyze supplier metrics to ensure high-purity, reproducible data in preclinical mitochondrial research.
Navigating MOTS-c price comparisons requires evaluating more than nominal cost per vial; researchers must assess active peptide content, analytical verification, and manufacturing compliance. This guide outlines how to analyze supplier metrics to ensure high-purity, reproducible data in preclinical mitochondrial research.
A rigorous MOTS-c price comparison evaluates the true cost per milligram of active, pure sequence rather than simple vial pricing. Low-cost options frequently compromise on sequence fidelity, contain elevated counterion concentrations, or lack independent lot-specific verification. High-value research procurement prioritizes verified >98% purity, strict endotoxin control (<0.01 EU/µg), and full ISO 17025 COA documentation over low baseline purchase prices.
When comparing vendors for institutional procurement, calculating cost per verified milligram—factoring in trifluoroacetic acid (TFA) removal, mass spectrometry validation, and lot-to-lot consistency—ensures experimental integrity while optimizing laboratory budgets.
MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA Type-c) is a 16-amino acid peptide derived from the mitochondrial genome. Unlike nuclear-encoded peptides, MOTS-c represents a class of mitochondrial-derived peptides (MDPs) that play specialized roles in retrograde signaling between the mitochondria and the nucleus.
In vitro models demonstrate that MOTS-c targets metabolic pathways by translocating to the nucleus under metabolic stress conditions, where it interacts with transcription factors such as NRF2. When procuring compounds for mitochondrial peptide research, maintaining structural integrity is essential, as even minor sequence truncation or amino acid substitution during solid-phase peptide synthesis (SPPS) can significantly alter receptor binding kinetics and downstream intracellular signaling.
Preclinical studies indicate that MOTS-c is a key regulator of systemic metabolic homeostasis. In rodent models, administration of synthesized MOTS-c has been observed to promote AMP-activated protein kinase (AMPK) phosphorylation, enhance insulin sensitivity, and modulate lipid oxidation pathways.
Additionally, investigator-led studies have explored the role of MOTS-c in exercise capacity research. Animal models subjected to physical exertion protocols demonstrate changes in skeletal muscle metabolic plasticity and glucose uptake when exposed to exogenous MOTS-c. Researchers evaluating these mechanisms rely on high-purity samples from our comprehensive research peptide catalog to prevent baseline cellular toxicity from non-target peptide fragments.
The price of synthesis for a mitochondrial peptide like MOTS-c is directly correlated with the complexity of solid-phase peptide synthesis, purification steps, and analytical testing. A thorough MOTS-c price comparison must account for several critical manufacturing stages that dictate final compound cost:
1. **Purity Determination via RP-HPLC**: Reverse-Phase High-Performance Liquid Chromatography separates the target sequence from incomplete deletion sequences. Reaching a verified purity of >98% requires multiple purification passes, increasing raw yield costs compared to crude or 90% pure grades. 2. **Mass Spectrometry Validation**: Electrospray Ionization Mass Spectrometry (ESI-MS) confirms the exact molecular mass (1875.1 Da). Vendors omitting MS analysis cannot guarantee sequence accuracy. 3. **TFA Counterion Depletion**: Peptides synthesized via Fmoc chemistry retain trifluoroacetic acid salts. Specialized salt exchange (e.g., to acetate or chloride forms) adds cost but prevents TFA-induced cytotoxicity in sensitive cell cultures. 4. **Endotoxin Quantification**: Limulus Amebocyte Lysate (LAL) testing ensures endotoxin levels remain below stringent thresholds suitable for delicate cellular and animal assays.
Purchasing departments often focus on price per vial, which can obscure significant variations in actual yield and peptide content. A 5mg vial listed at a low price point may contain up to 30% filler (such as excess lyoprotectants or residual salts) or exhibit purity levels below 90%, yielding significantly less active peptide than advertised.
To calculate true cost efficiency, researchers should multiply the gross mass by the certified RP-HPLC purity percentage and subtract known counterion mass. Evaluating pricing through this standardized metric ensures that laboratory funds are allocated toward pure, biologically active material rather than analytical unreliability or filler components.
When designing metabolic or mitochondrial research protocols, laboratories frequently evaluate MOTS-c alongside other compounds targeting cellular energetics. A direct comparison highlights distinct operational targets across this research class:
In preclinical settings, MOTS-c works primarily via nuclear translocation and AMPK pathway regulation, whereas SS-31 directly targets cardiolipin on the inner mitochondrial membrane to alleviate oxidative stress. Concurrently, Humanin, another mitochondrial-derived peptide, is primarily studied for cytoprotective and anti-apoptotic mechanisms. Assessing these complementary peptides within our research hub assists investigators in choosing the precise mechanism required for their experimental models.
To preserve the bioactivity of MOTS-c post-procurement, adherence to strict laboratory handling protocols is required. Lyophilized MOTS-c should be stored at -20°C or -80°C upon arrival, protected from light and moisture desiccation.
Reconstitution should be conducted within a certified laminar flow hood using sterile, laboratory-grade bacteriostatic water or sterile phosphate-buffered saline (PBS, pH 7.4). Avoid high-shear vortexing, which can denature the tertiary structure; gentle swirling is recommended. Once reconstituted, create single-use aliquots to prevent repeated freeze-thaw cycles, which accelerate peptide degradation and fragment formation.
Vendor reliability is the single most critical factor when conducting a MOTS-c price comparison. Low-cost overseas suppliers frequently provide static or generic Certificates of Analysis (COAs) that are not lot-specific or originate from unaccredited internal testing setups.
PX1 Research maintains rigorous quality control by manufacturing all compounds domestically in the USA within cGMP-compliant facilities. Every single lot undergoes independent, third-party testing at ISO 17025 accredited laboratories using RP-HPLC and ESI-MS. Full lot traceability and public access to COAs guarantee that institutional buyers receive exact-purity compounds with every order.
Utilizing sub-standard or unverified peptides introduces significant variables into research assays. Impurities such as truncated peptide fragments can act as competitive antagonists to native receptors, skewing binding affinity data and metabolic flux measurements.
Furthermore, high levels of bacterial endotoxins or residual organic solvents from improper washing during synthesis induce inflammatory responses in cell cultures or animal models, masking the true physiological actions of MOTS-c. Sourcing fully verified compounds mitigates these experimental artifacts and ensures data reproducibility.
For large-scale animal studies or multi-phase cellular research programs, individual vial procurement can rapidly inflate operational costs. Establishing institutional workflow accounts allows research facilities to secure consistent lot batches while optimizing expenditure.
Principal investigators and laboratory managers can explore volume discounts, dedicated lot reservation, and specialized supply chain integration via wholesale research accounts. Direct access to specialized support ensures seamless fulfillment with same-day shipping from our CA and AZ facilities.
Why do MOTS-c prices vary significantly between suppliers?
Price variances reflect differences in synthesis methods, purification standards (e.g., >98% HPLC purity vs crude), trifluoroacetic acid (TFA) removal, and independent ISO 17025 third-party COA testing. Cheaper options often omit rigorous endotoxin testing or lot-specific mass spectrometry validation.
How can I verify the purity of a MOTS-c batch?
Review a lot-specific Certificate of Analysis (COA) generated by an independent ISO 17025 accredited laboratory. The COA must include a clear RP-HPLC chromatogram showing peak purity percentage and an ESI-MS mass spectrum matching the theoretical mass of MOTS-c (1875.1 Da).
What is the recommended storage temperature for lyophilized MOTS-c?
Lyophilized MOTS-c should be stored at -20°C or -80°C in a dry environment protected from light. Under these conditions, the lyophilized powder remains stable for extended laboratory storage periods.
What solvent should be used for MOTS-c reconstitution in cell culture assays?
MOTS-c is typically reconstituted using sterile laboratory-grade bacteriostatic water, sterile normal saline, or PBS (pH 7.4) under sterile laminar flow hood conditions, depending on the requirements of the specific in vitro or in vivo protocol.
What are the endotoxin limits for high-grade research MOTS-c?
High-grade research peptides intended for preclinical animal studies or sensitive cell cultures should feature endotoxin levels strictly verified at <0.01 EU/µg using standardized LAL assays.
How does MOTS-c compare in price to other mitochondrial peptides like SS-31?
Pricing differs based on peptide sequence length, amino acid complexity, and synthesis yield. While MOTS-c is a 16-amino acid sequence, peptides like SS-31 are smaller tetrapeptides, altering synthesis costs per gram depending on scale and purification parameters.
Can PX1 Research provide bulk or dedicated lot reservations for MOTS-c?
Yes, academic institutions and commercial laboratories can establish dedicated lot reservations and bulk procurement contracts through PX1 Research wholesale accounts to ensure lot-to-lot consistency across long-term studies.
Where are PX1 Research peptides manufactured and shipped from?
All PX1 Research compounds are manufactured in domestic USA cGMP-compliant facilities and shipped directly from fulfillment centers in California and Arizona with same-day dispatch for orders placed Monday through Friday.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.